Current Affairs for 29 September 2026

India’s Oscar Strategy: Rethinking Film Selection and Global Campaigning

Why in News?

The selection of India’s official entry for the Best International Feature Film category at the 99th Academy Awards has renewed debate over India’s Oscar strategy. The discussion centres on whether selection should focus primarily on Indian cultural representation or give greater weight to cinematic merit, international visibility and effective campaigning.

Background

The Film Federation of India (FFI) is responsible for selecting India’s official entry for the Academy Awards’ Best International Feature Film category.

India’s Oscar selections have frequently generated debate. Some notable examples include:

• The Good Road was selected over The Lunchbox in 2013. 
• Chhello Show was selected as India’s official entry instead of RRR. 
• RRR, despite not being India’s official entry, conducted a major international awards campaign and won the Oscar for Best Original Song for Naatu Naatu. 

Key Issue: Cultural Representation vs Cinematic Merit

The FFI has often emphasised selecting films that represent Indian culture.

However, cultural representation alone may not determine success at international film awards. A strong contender also requires:

• Powerful storytelling 
• Strong direction and performances 
• Technical excellence 
• Distinctive cinematic vision 
• Social or human relevance 
• International visibility 

Key point: Cultural specificity can become a strength when it is combined with strong filmmaking and a compelling universal narrative.

Importance of International Recognition

International film festivals can significantly increase a film’s global visibility.

Recognition at platforms such as:

• Cannes Film Festival 
• Toronto International Film Festival (TIFF) 
• Venice Film Festival 

can help films attract international critics, distributors, studios and awards-season attention.

Why Oscar Campaigning Matters

• Oscar success is not based solely on the quality of a film. For major contenders, strategic international campaigning and sustained visibility are also important. -A typical awards-season pathway can be understood as: Festival Premiere → Critical Recognition → International Release → Awards Campaign → Academy Visibility → Voting
• The experience of RRR demonstrates the importance of this approach. Although it was not India’s official entry for Best International Feature Film, its international campaign generated substantial visibility and contributed to its success in the wider awards circuit.

Major Challenges for India

1. Selection-related debates:- The choice of India’s official entry often generates discussion within the film industry and among audiences.
2. Limited global visibility :-Many Indian films with strong cinematic credentials may not receive sufficient exposure at major international platforms.
3. Campaigning infrastructure :- International awards campaigns require financial resources, professional networks and sustained promotional strategies.
4. Diversity of Indian cinema: -India’s linguistic, regional and cultural diversity makes it difficult for a single film to represent the entire country.
5. Domestic vs international success:- A film that is highly successful in India may not necessarily receive similar recognition from international audiences or Academy voters.

Way Forward

India can approach the Oscars through a broader international cinema strategy rather than viewing selection only through the lens of cultural representation.

Key measures include:-

• Giving due importance to cinematic quality, originality and artistic vision during selection. 
• Increasing the participation of Indian films in major international film festivals. 
• Developing professional international campaigns at an early stage. 
• Strengthening collaboration between filmmakers, studios and international distributors. 
• Improving subtitling, dubbing and global distribution of regional-language films. 
• Leveraging Indian cinema as an instrument of cultural diplomacy and soft power. 

FAQs

PRAHAAR Counter-Terrorism Policy 2026: India’s National Strategy against Terrorism

Why in News?

• Union Home Minister Amit Shah unveiled PRAHAAR Counter-Terrorism Policy and Strategy at a national counter-terrorism conference in New Delhi.
• The conference focused on implementing PRAHAAR through a whole-of-government and whole-of-society approach. The Home Minister emphasised that its principles should reach the police-station level and called for a proactive and result-oriented approach to counter-terrorism.
• The conference was attended by DGPs of 15 States and Anti-Terrorism Squad (ATS) chiefs from all States and Union Territories.

What is PRAHAAR?

• PRAHAAR is India’s comprehensive National Counter-Terrorism Policy and Strategy, designed to strengthen the country’s institutional response to terrorism.
• It moves beyond a purely reactive security response by integrating prevention, intelligence coordination, rapid response, human rights, international cooperation and post-attack resilience.
• The strategy seeks to bring together central and state governments, security agencies, law-enforcement institutions, international partners and wider society in a coordinated counter-terrorism framework.

Seven Pillars of PRAHAAR

1. Prevention: The focus is on preventing terrorist attacks through intelligence gathering, surveillance, early identification of threats and timely intervention.
2. Response: It aims to establish a rapid, coordinated and effective response mechanism for terrorist incidents, with institutionalised counter-terrorism responses at different levels.
3. Aggregating Internal Capacities: This pillar focuses on integrating the capabilities and resources of different central and state agencies to improve intelligence sharing, investigation and operational coordination.
4. Human Rights: Counter-terrorism operations are expected to remain consistent with human rights, constitutional principles and the Rule of Law.
5. Attenuating Conditions for Terrorism: The strategy seeks to address conditions that can facilitate terrorism, including radicalisation, terrorist recruitment and other factors that enable extremist networks.
6. Aligning International Efforts: Since terrorism increasingly operates across national borders, PRAHAAR emphasises international cooperation, intelligence sharing, extradition and coordinated action against transnational terrorist networks.
7. Recovery & Resilience: This pillar focuses on restoring normalcy after terrorist incidents and strengthening the resilience of communities, institutions and critical systems.

Key Highlights of PRAHAAR Conference 2026

• Amit Shah stressed that the principles of PRAHAAR must percolate down to the police-station level. He also called for a proactive approach to every aspect of the strategy.
• The Home Minister emphasised the need to institutionalise an automated counter-terrorism response at every level and called for a result-oriented implementation of all seven pillars.
• He also highlighted the importance of coordination among different stakeholders to prevent delays in counter-terrorism operations.

Extradition Portal

• A new Extradition Portal was launched during the conference to improve coordination among agencies involved in bringing fugitives back to India.
• According to the Home Minister, between 2019 and 2026, 288 fugitive criminals were brought back to India from 36 countries.
• The initiative highlights the growing importance of international legal and institutional cooperation in tackling transnational crime and terrorism.

Action against Shahzad Bhatti Network

Amit Shah also highlighted inter-agency action against the Shahzad Bhatti network, which was linked to cross-border smuggling of weapons, explosives and narcotics.

According to the government:

• More than 40 modules were busted.
• More than 100 FIRs were registered.
• Around 350 individuals were arrested.
• The action extended across 15 States.

This illustrates the importance of intelligence sharing and coordination between central and state agencies in tackling organised and cross-border networks.

Significance of PRAHAAR

• PRAHAAR is significant because it seeks to create an integrated counter-terrorism framework rather than treating terrorism only as a law-and-order or policing challenge.
• Its seven-pillar framework covers the complete counter-terrorism cycle from prevention and response to international cooperation, recovery and resilience.
• The emphasis on a whole-of-society approach also recognises that countering terrorism requires cooperation beyond security agencies, including government institutions, communities, technology stakeholders and international partners.

Challenges

• Centre-State Coordination: India’s federal structure requires sustained coordination between central agencies and state police forces. Differences in capabilities, intelligence systems and operational procedures can affect real-time information sharing.
• Emerging Technology: Terrorist and organised criminal networks are increasingly exploiting technologies such as encrypted communications, drones, cyber platforms and digital financial systems.
• Terror Financing: Tracking illicit financial flows remains a major component of counter-terrorism efforts, particularly when funds move through complex domestic and international networks.
• Human Rights and Security: Effective counter-terrorism measures need to operate within the constitutional framework and maintain a balance between national security, individual rights and the Rule of Law.
• Transnational Terrorism: Cross-border movement of terrorists, weapons, narcotics, funds and fugitives makes international cooperation essential for effective counter-terrorism.

Way Forward

• Effective implementation of PRAHAAR requires stronger intelligence integration, police modernisation, inter-agency coordination and capacity building of state ATS and Counter-Terrorism Units.
• Technology-driven intelligence systems should be strengthened to detect emerging threats, while cyber intelligence, drone monitoring and terrorist-financing investigations should be integrated into the broader counter-terrorism architecture.
• International cooperation should also be strengthened through intelligence sharing, extradition mechanisms and coordinated action against transnational networks.
• Most importantly, the whole-of-society approach should ensure that counter-terrorism becomes a coordinated effort involving government agencies, law-enforcement institutions.

FAQs

Rare-Disease Drugs: India’s Next Pharma Frontier

Why in News?

• India is emerging as a potential hub for rare-disease drug development and manufacturing. 
• Despite having a large number of rare-disease patients, access to medicines remains limited because of their extremely high cost and the lack of treatments for most rare diseases.
• The article argues that India can leverage its strengths in generic drugs, biosimilars, clinical research and low-cost manufacturing to build a globally competitive rare-disease pharmaceutical sector.

What Are Rare Diseases?

• Rare diseases are conditions that affect a very small proportion of the population individually. 
• However, there are around 8,000 rare diseases globally, collectively affecting hundreds of millions of people.
• In India, around 1,004 rare genetic disorders have been reported.Because the number of patients for an individual disease is small, pharmaceutical companies historically had limited commercial incentives to develop medicines for these conditions. Hence, such medicines are often called “orphan drugs.”

Why Are Orphan Drugs Expensive?

Developing a drug for a rare disease involves:

• A small patient population for clinical trials. 
• Difficulty in identifying suitable patients. 
• Limited commercial markets. 
• High research and development costs. 
• Complex manufacturing, particularly for gene and cell therapies. 

Consequently, companies may charge extremely high prices. For example, some rare-disease therapies can cost millions of dollars for a single treatment, while certain medicines may cost hundreds of thousands of dollars annually. This creates a major problem of affordability and access, particularly in developing countries.

Global Experience: Orphan Drug Act

The U.S. enacted the Orphan Drug Act in 1983 to encourage the development of medicines for rare diseases.

It provided incentives such as:

• Tax incentives. 
• Grants. 
• Regulatory fee waivers. 
• Market exclusivity for qualifying products. 

According to the article, before the Act, only 38 relevant drugs had been approved in the U.S.; by 2022, the number of approvals had increased to 1,122. Similar policy frameworks were subsequently introduced in countries and regions such as Japan, Australia and the European Union.

India’s Rare-Disease Challenge

• India has introduced financial assistance of up to ₹50 lakh for eligible rare-disease patients under the national framework.
• However, this amount may be insufficient because some therapies can cost several crores of rupees.
• The article highlights a case in which around ₹9 crore was raised through crowdfunding for gene therapy for a child in Kolkata.
• Another major problem is the limited availability of treatments. According to the article, existing drugs address only around 5% of rare diseases and associated conditions.
• Therefore, India faces two interconnected challenges: Affordability + Availability

Major Challenges in Developing Rare-Disease Drugs

1. Small Patient Population :- The limited number of patients for an individual rare disease makes clinical trials difficult.
2. Difficulty in Clinical Trials :- Researchers need to identify appropriate patient cohorts and suitable clinical endpoints.
3. High R&D Cost :- Gene therapies, cell therapies and other advanced treatments require substantial investment.
4. Manufacturing at Small Scale :- Rare-disease medicines may need to be manufactured in relatively small quantities while maintaining high quality and safety standards.
5. High Drug Prices :- Limited markets and high development costs can lead to very high prices.
6. Limited Treatment Options :-Many rare diseases still do not have an effective approved treatment.
7. Limited Participation of Indian Patients :-Indian patients are not sufficiently represented in international clinical trials for orphan drugs.

Why India Can Become a Rare-Disease Drug Hub?

India has several structural advantages.

1. Large Patient Population

• With a population exceeding 1.4 billion, even rare conditions can involve a significant number of patients.
• Certain communities also have higher prevalence of particular genetic disorders because of patterns such as endogamy.
• For example, the article cites beta-thalassemia prevalence of 10.5% in particular Indian ethnic groups, compared with 3.7% in the general Indian population according to a 2023 review.

2. Patient Advocacy Groups

• Disease-specific patient organisations and registries are increasingly emerging in India.
• Examples mentioned include:
  • GNE myopathy research involving a group of 70 people. 
  • Rett syndrome patient registries involving more than 400 patients. 
  • Such databases can help researchers identify suitable participants for clinical trials.

3. Pharmaceutical Manufacturing Capacity

• India is known as the “pharmacy of the world” because of its large-scale production of affordable medicines.
• The article highlights India's strengths in:
  • Generic medicines. 
  • Biosimilars. 
  • Small-molecule drugs. 
  • CAR-T cell therapy. 
  • Low-cost pharmaceutical manufacturing. 

4. Existing Export Ecosystem

• Indian pharmaceutical companies already supply medicines to major global markets, creating an ecosystem that could potentially be extended to rare-disease medicines.

Regulatory Opportunity: Rule 101

• Under Rule 101 of the New Drugs and Clinical Trials Rules, 2019, CDSCO has recognised certain countries, including the U.S. and U.K., for regulatory purposes.
• For specified drugs approved in these jurisdictions, a new clinical trial in India may not be required before seeking Indian regulatory approval, subject to applicable regulatory requirements.

Significance

This can:

• Reduce duplication of clinical trials. 
• Reduce development time. 
• Lower regulatory costs. 
• Facilitate availability of medicines in India. 
• Encourage domestic manufacturing of approved rare-disease medicines. 

However, the article argues that greater regulatory transparency and clear guidance documents are required.

What Should India Do?

1. Create a Streamlined Regulatory Pathway

• India should simplify regulatory procedures for rare-disease medicines while maintaining:
  • Safety standards. 
  • Efficacy requirements. 
  • Bioequivalence standards where applicable. 
  • Toxicity assessment. 
  • Pharmacovigilance. 
  • Good manufacturing practices. 

2. Encourage Clinical Trials in India

• The government can facilitate partnerships between:
• Foreign pharmaceutical companies + Indian research institutions + Patient groups
• This can increase Indian participation in international rare-disease trials.

3. Provide Financial Incentives

• India could develop incentives similar to Production Linked Incentive (PLI) schemes.
• Incentives could be linked to:
  • Production. 
  • Investment. 
  • Exports. 
  • Patient access. 

4. Promote Technology Transfer

National laboratories and research institutions can collaborate with companies on:

• Technology transfer. 
• Process development. 
• Manufacturing technologies. 

5. Government Procurement

• The government could provide Advance Market Commitments (AMCs) by committing to purchase specified quantities of medicines at predetermined prices.
• This would reduce market uncertainty for manufacturers.

6. Use Existing Public Health Networks

Rare-disease medicines could potentially be distributed through:

• Centres of Excellence for Rare Diseases. 
• Central Government Health Scheme. 
• Pradhan Mantri Bhartiya Janaushadhi Kendras. 

7. Promote Exports to Developing Countries

• India could leverage its low-cost manufacturing capability to supply affordable rare-disease medicines to low- and middle-income countries.

Benefit-Sharing and Rare-Disease Research

• An important concept discussed in the article is benefit-sharing.
• The underlying idea is that when countries, patients or communities contribute biological information and genetic data to research, the benefits arising from resulting medicines and technologies should be shared fairly.
• This principle has also been discussed in the context of the WHO Pandemic Agreement, particularly regarding pathogen information and equitable access to resulting medical products.
• For India, benefit-sharing could mean ensuring that Indian patients participating in clinical research are able to access the resulting medicines at affordable prices.

Way Forward

• India should move from being primarily a low-cost generic medicine manufacturer towards becoming a complete ecosystem for rare-disease medicines.
• This requires a coordinated approach involving:
• Research → Patient Registries → Clinical Trials → Regulatory Facilitation → Manufacturing → Government Procurement → Affordable Access
• The objective should not merely be to subsidise pharmaceutical companies. Instead, government intervention should de-risk initial investments sufficiently to make rare-disease drug manufacturing commercially viable.

FAQs

World Heart Day 2026: Cardiovascular Diseases, Risk Factors and Global Heart Health

Why in News?

• World Heart Day is observed every year on 29 September and is led globally by the World Heart Federation to increase awareness about cardiovascular health. The 2026 campaign focuses on recognising hidden or overlooked symptoms of cardiovascular disease and encouraging preventive action.
• The campaign also calls for stronger cardiovascular-health systems, including national action plans, prevention, early detection and equitable access to treatment. The WHF notes that fewer than 20 countries currently have a standalone national plan specifically addressing CVDs.

What is World Heart Day?

World Heart Day is an annual global health-awareness campaign focused on cardiovascular diseases. The idea was introduced by the World Heart Federation in 1999 with support from WHO, while the first official World Heart Day was observed in 2000. Since 2011, it has been observed on a fixed date, 29 September.

Cardiovascular Diseases: Key Facts

• Cardiovascular diseases are a group of disorders affecting the heart and blood vessels, including coronary heart disease, cerebrovascular disease, rheumatic heart disease and congenital heart disease. WHO identifies CVDs as the leading cause of death globally, with around 19.8 million deaths estimated in 2022.
• Heart attacks and strokes account for the majority of cardiovascular deaths. Major preventable risk factors include tobacco use, unhealthy diet, physical inactivity, harmful alcohol use, high blood pressure, high blood glucose and abnormal blood lipids.

Major Risk Factors

• The risk of cardiovascular disease is influenced by behavioural, metabolic and environmental factors. Tobacco use, unhealthy diets, physical inactivity and harmful alcohol consumption can contribute to conditions such as hypertension, obesity, diabetes and high cholesterol.
• Air pollution is also an important environmental risk factor. WHO highlights that improving air quality, promoting physical activity and making healthy food choices more accessible can contribute to reducing cardiovascular risks.

Global and Developmental Significance

• Cardiovascular diseases are not only a medical issue but also a development challenge, particularly for low- and middle-income countries. More than three-quarters of CVD deaths occur in these countries, where gaps in early detection, primary healthcare and access to essential medicines can increase the burden.
• The WHO Global Hearts Initiative, launched in 2016, seeks to strengthen cardiovascular disease prevention and management through primary healthcare and supports the global goal of reducing premature deaths from CVDs by one-third by 2030.

Challenges

Major challenges include delayed diagnosis, inadequate awareness of symptoms, unequal access to healthcare and insufficient prevention of hypertension, diabetes and high cholesterol. Cardiovascular risks are also influenced by urbanisation, ageing populations, unhealthy lifestyles and environmental pollution.

Way Forward

A comprehensive approach should focus on prevention, early screening, stronger primary healthcare, affordable medicines, healthier urban environments and public awareness. Governments can also strengthen national cardiovascular-health plans and integrate CVD prevention into broader non-communicable disease strategies.

FAQs

India-UAE High Level Joint Task Force on Investments: 14th Meeting, Key Outcomes and Strategic Significance

Why in News?

• The 14th Meeting of the India-UAE High Level Joint Task Force on Investments (HLJTFI) was held in Mumbai and co-chaired by Piyush Goyal, Union Minister of Commerce & Industry, and Sheikh Hamed bin Zayed Al Nahyan, Managing Director of the Abu Dhabi Investment Authority (ADIA).
• The meeting reviewed the progress of bilateral investment initiatives and explored new areas of cooperation in energy, infrastructure, logistics, technology, artificial intelligence, space, food security, agriculture and startups.
• The meeting assumes significance as India-UAE economic relations have expanded beyond traditional trade towards investment, financial technology, infrastructure and strategic sectors.

What is the India-UAE High Level Joint Task Force on Investments?

The High Level Joint Task Force on Investments (HLJTFI) was established in 2013 by India and the UAE.

It serves as an institutional mechanism to:

• Promote bilateral investment flows.
• Identify new investment opportunities.
• Facilitate economic cooperation between India and the UAE.
• Address concerns faced by investors of both countries.
• Resolve investment-related issues through regular high-level dialogue.

The Joint Task Force has therefore become an important component of the broader India-UAE economic partnership.

Key Outcomes of the 14th Meeting

1. Progress in Joint Investment Projects

The two sides reviewed progress in several investment projects, including the Food Park project in Gujarat. They also discussed opportunities for expanding cooperation in sectors such as infrastructure, logistics, industry and technology.

2. Major UAE Investments in India

The meeting noted several significant recent investment developments, including:

• Emirates NBD: Approximately US$3 billion acquisition of a majority stake in RBL Bank.
• International Holding Company (IHC): Around US$1 billion investment in Sammaan Capital.
• Integrated Aluminium Complex in Odisha: Joint investment intent of approximately US$11.5 billion.

These developments highlight the growing role of UAE-based investors in India's financial and industrial sectors.

3. Expansion of Financial-Sector Cooperation

Financial cooperation was identified as an important pillar of the bilateral economic relationship. The Reserve Bank of India and Central Bank of the UAE are working on initiatives involving:

• Local-currency settlement.
• Integration of payment systems.
• Integration of financial messaging systems.
• Central Bank Digital Currencies (CBDCs).

Such measures can potentially reduce transaction costs and make bilateral trade and investment more efficient.

4. Investment Facilitation

The two sides noted the expected operationalisation of an Invest India office in the UAE before the end of 2026.

The office is expected to facilitate investment-related engagement and strengthen connections between investors and Indian opportunities.

5. GIFT City Cooperation

The meeting also noted the opening of branch offices of:

• Mashreq Bank
• First Abu Dhabi Bank (FAB)
• Abu Dhabi National Insurance Company (ADNIC)

This reflects the growing financial-sector linkages between India and the UAE.

6. Energy Cooperation

The two sides reviewed cooperation in the energy sector under the MoUs signed during Prime Minister Narendra Modi's visit to the UAE in May 2026.

Energy remains an important area of bilateral cooperation because of India's energy requirements and the UAE's position as a major energy-producing and investment economy.

7. Aviation and Dholera Logistics Hub

Civil aviation cooperation between Abu Dhabi and India was also discussed.

The two countries explored investment and cooperation opportunities related to developing an aviation and logistics hub at Dholera in Gujarat.

New Areas of Cooperation

The Joint Task Force identified several sectors with potential to increase two-way investment flows:

• Energy
• Industry and manufacturing
• Logistics
• Infrastructure
• Technology and Artificial Intelligence
• Space
• Food security
• Agricultural innovation
• Startups

This indicates that India-UAE economic relations are increasingly moving towards technology-intensive and strategic sectors.

India-UAE Fast Track Mechanism

The two sides also reviewed the UAE–India Fast Track Mechanism, which is designed to address outstanding issues affecting:

• UAE investments and companies operating in India.
• Indian investments and companies operating in the UAE.

The mechanism provides an additional institutional channel for resolving investment-related concerns and improving the business environment.

Strategic Significance of India-UAE Economic Partnership

The India-UAE relationship has evolved from a primarily trade-oriented relationship into a broader economic and strategic partnership.

The UAE is important for India because of its role as:

• A major investment partner.
• An important energy partner.
• A financial and logistics hub.
• A gateway to West Asia and wider global markets.
• A significant destination for Indian businesses and the Indian diaspora.

For the UAE, India's large consumer market, expanding infrastructure, digital economy and growth opportunities provide significant avenues for investment.

Challenges

Despite growing economic cooperation, several challenges remain:

• Investment and Regulatory Issues: Differences in regulatory frameworks and business procedures can affect the speed of investment implementation.
• Project Execution: Large-scale investment commitments need effective coordination, land availability, infrastructure and timely regulatory clearances.
• Financial Integration: Local-currency settlement and payment-system integration require interoperability, regulatory coordination and adequate safeguards.
• Sectoral Diversification: Bilateral investment needs to expand further into emerging areas such as AI, advanced manufacturing, space technology and clean energy.

Way Forward

India and the UAE can strengthen the partnership by:

• Expediting the implementation of announced investment projects.
• Strengthening the Fast Track Mechanism for resolving investor concerns.
• Expanding cooperation in AI, digital infrastructure, space and advanced manufacturing.
• Promoting greater use of local-currency settlement mechanisms.
• Deepening cooperation between GIFT City and UAE financial institutions.
• Strengthening aviation, logistics and supply-chain connectivity.
• Supporting startups and innovation ecosystems in both countries.

FAQs

TakeMe2Space to Launch India’s First Orbital Computing Satellite via SpaceX

Why in News?

• Indian space startup TakeMe2Space is set to launch its MOI-1A orbital computing satellite on October 1, 2026, aboard SpaceX’s Transporter-18 rideshare mission.
• The mission aims to process data directly in space using onboard computing and Artificial Intelligence (AI), reducing the need to send large amounts of raw data back to Earth.

What is MOI-1A?

• MOI-1A is a small orbital computing satellite developed by TakeMe2Space. The spacecraft weighs around 14 kg and is designed in a 6U CubeSat configuration.
• It is equipped with NVIDIA Orin NX edge-computing processors, which can provide up to 117 trillion operations per second (TOPS) of computing capability.
• The satellite also features:
  • 2 terabytes of onboard storage
  • Nine-band multispectral imaging
  • Peak power capacity of around 120 watts
  • Onboard AI and edge-computing capabilities

How Will Orbital Computing Work?

• Normally, Earth-observation satellites collect large amounts of data and transmit the raw data to ground stations for processing.
• MOI-1A will follow a different approach. Customers will be able to upload AI models to the satellite. The satellite will then process the data while passing over a particular region.
• After processing, it will send the results or analysis back to Earth instead of transmitting the complete raw dataset.
• This can help reduce data-transfer requirements, processing time and the cost of downloading large datasets.

Applications of the Satellite

TakeMe2Space has signed 23 customers for the mission, according to company statements reported by Reuters.

Potential applications include:

• Geospatial and Geographic Information Systems (GIS) 
• Agriculture 
• Mining 
• Supply-chain management 
• Insurance 
• Education 
• Space-data analytics 

US-based space-data analytics company Little Place Labs is among the customers.

From Technology Demonstration to Commercial Mission

• TakeMe2Space previously conducted a technology-demonstration mission in late 2024.
• The mission demonstrated the company's ability to:
  • Upload applications to a spacecraft
  • Perform AI inference in orbit
  • Process data in space
  • Download the resulting information to Earth
• A subsequent MOI-1 satellite was lost following a third-stage failure of its launch vehicle.
• The upcoming MOI-1A mission is therefore aimed at taking the company's orbital-computing technology towards commercial operations.

Future Plans of TakeMe2Space

• TakeMe2Space plans to develop larger and networked satellites from 2027.
• The objective is to increase computing capacity, serve multiple customers and reduce the cost of orbital computing.
• The company also plans to explore orbital cold storage, which would involve storing critical data in space as an additional backup location beyond terrestrial cloud infrastructure.
• The proposed service could target sectors such as financial services and defence.

India’s Growing Space-Tech Ecosystem

• The development of MOI-1A reflects the growing role of private space startups in India’s space sector.
• TakeMe2Space designs and manufactures most of its satellite subsystems in India, while some components such as computing chips, solar cells and propulsion systems are sourced externally.
• The mission also highlights the growing integration of space technology, artificial intelligence and edge computing.

Significance

• The MOI-1A mission represents a shift from simply collecting and transmitting satellite data towards processing data directly in orbit.
• With the growing use of Artificial Intelligence and satellite-based Earth observation, orbital computing could help reduce the volume of data that needs to be transmitted to Earth and enable faster access to processed information.

Conclusion

TakeMe2Space’s MOI-1A mission represents an emerging approach in which satellites can collect, process and analyse data in orbit before transmitting the results to Earth. By combining satellite technology with artificial intelligence and edge computing, the mission aims to reduce the need for transmitting large volumes of raw data and create new commercial applications for space-based computing.

FAQs

India–Kazakhstan Exercise KAZIND 2026: Key facts, Objectives, Major Activities, Defence Cooperation and Significance

Why in news?

The India–Kazakhstan Joint Military Exercise is being conducted from 28 September to 11 October 2026.

Key Facts

What is Exercise KAZIND?

• KAZIND is a joint military exercise between India and Kazakhstan. It provides a platform for the armed forces of both countries to train together and exchange operational experience.
• The exercise primarily focuses on improving interoperability, coordination and joint operational capability. Counter-insurgency and counter-terrorism operations under a UN mandate have been important components of previous editions.
• The exercise has gradually expanded to incorporate air-force participation and emerging technologies.

Indian Contingent in KAZIND-2026

• India has deployed a 60-member Armed Forces contingent. The contingent is primarily drawn from a battalion of the GARHWAL RIFLES.
• Personnel from other arms and services of the Indian Army are also participating. The contingent also includes personnel from the Indian Air Force.
• Kazakhstan is fielding a contingent of matching strength, consisting primarily of personnel from its Land Forces.

Major Objectives of KAZIND-2026

• Enhance Interoperability: Improve the ability of Indian and Kazakh forces to operate together. Develop better coordination in planning and execution of joint missions.
• Counter-Terrorism Preparedness: Improve joint capability to respond to terrorist threats. Practise counter-terrorism operations in a sub-conventional environment.
• Exchange Operational Experience: Enable both forces to learn from each other's operational experience. Exchange tactics, techniques and procedures used in counter-terrorism operations.
• Strengthen Defence Cooperation: Build professional bonds between the armed forces. Strengthen mutual trust and military-to-military cooperation.

Major Activities during KAZIND-2026

• Joint Response to Terrorist Actions: Troops will practise coordinated responses to simulated terrorist threats.
• Raids: Joint teams will practise raids against identified targets.
• Search-and-Destroy Missions: Forces will train to locate and neutralise simulated hostile elements.
• Cordon-and-Search Operations: Troops will practise securing an area and conducting systematic searches.
• Securing Helipads and Landing Sites: Training will include securing areas required for helicopter-based operations.
• Special Heliborne Operations: Personnel will practise the rapid deployment of troops using helicopters.

Focus on Drones and Counter-Drone Capabilities

• Unmanned Aerial Systems: Support military operations through surveillance, reconnaissance, situational awareness and monitoring of operational areas. 
• Counter-UAS: Designed to identify and respond to hostile or unauthorised unmanned aerial systems.
• Joint Command Post: It will facilitate coordinated planning between the participating contingents, support joint decision-making and execution of operations and provides experience in integrating the command structures of two different armed forces.
• Intelligence and Surveillance Centre: It will support coordinated operational planning and execution. Intelligence and surveillance are important for identifying threats and improving situational awareness during counter-terrorism operations.
• Comprehensive Validation Exercise: Indian and Kazakh contingents will jointly respond to a simulated terrorist threat. They will apply the tactics, techniques and procedures (TTPs) practised during the exercise. It will test the ability of the two contingents to integrate their training into a coordinated operation.

India-Kazakhstan Defence Cooperation

• The current framework is based on the Agreement on Defence and Military Technical Cooperation, signed in July 2015.
• Defence cooperation includes Joint military exercises, Military education and training, Military-technical cooperation, Bilateral military visits, Joint sports and adventure activities and Youth exchanges. 
• India also provides training to personnel of the Kazakh Armed Forces under the Indian Technical and Economic Cooperation (ITEC) programme.
• The two countries have institutional mechanisms such as the Joint Working Group on Defence Cooperation.

UN Peacekeeping Cooperation

• India and Kazakhstan have also cooperated in United Nations peacekeeping operations. In 2018, the two countries agreed on the deployment of a Kazakh contingent under an Indian battalion in the United Nations Interim Force in Lebanon (UNIFIL).
• This cooperation provided personnel from both countries experience in operating together in a multinational UN environment.

Significance of Exercise KAZIND-2026

• Counter-Terrorism Cooperation: Strengthens coordination between India and Kazakhstan in responding to terrorism and other sub-conventional security threats.
• Military Interoperability: Regular joint training helps the armed forces understand each other's operational procedures and improves their ability to conduct coordinated missions.
• Modern Warfare Preparedness: Training involving UAS, Counter-UAS, intelligence, surveillance and air mobility provides exposure to technologies increasingly relevant to contemporary military operations.
• Defence Diplomacy: Joint military exercises provide an institutional mechanism for building trust and professional relationships between armed forces.
• Regional Peace and Stability: KAZIND reinforces the shared commitment of India and Kazakhstan towards regional peace, stability and collective security.

FAQs